Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ginkgo Extract Protects Brain from Stroke Damage

By LabMedica International staff writers
Posted on 20 Oct 2008
An extract prepared from leaves of the Ginkgo biloba tree, long favored in Chinese and alternative medicine to improve brain function, has been found to protect the brain from some of the damage caused by ischemic stroke.

Investigators at Johns Hopkins University (Baltimore, MD, USA) induced stroke-like damage in a population of laboratory mice by briefly blocking an artery to one side of the brain. More...
Some of the animals in the study were treated with the Ginkgo extract, EGb761, prior to the stroke, while some of the animals received the treatment after the stroke. A control group was not treated with the extract.

Results published in the October 9, 2008, online edition of the journal Stroke revealed that the pretreated animals had 50.9% less neurological dysfunction and 48.2% smaller areas of brain damage than untreated mice. Treatment five minutes or four and a half hours after the stroke also led to significant reduction in damage.

The experiment was carried out a second time on a population of mice that had been genetically engineered to lack the gene for the enzyme heme oxygenase-1 (HO-1). HO-1 breaks down heme into carbon monoxide, iron, and biliverdin. It has been shown to act as an antioxidant and have a protective effect against inflammation in animal models. The HO-1 deficient animals did not show any benefit from EGb761 treatment, either before or after the stroke.

"Our results suggest that some element or elements in ginkgo actually protect brain cells during stroke,” explained senior author Dr. Sylvain Doré, associate professor of anesthesiology and critical care medicine at Johns Hopkins University. "Ginkgo increases HO-1 levels, and the antioxidant properties of this enzyme eliminate free radicals at the surrounding regions of the stroke site. Ginkgo has long been touted for its positive effects on the brain and is even prescribed in Europe and Asia for memory loss. Now we have a possible understanding for how Ginkgo actually works to protect neurons from damage.”

"It is still a large leap from rodent brains to human brains but these results strongly suggest that further research into the protective effects of Ginkgo is warranted,” said Dr. Doré. "If further work confirms what we have seen, we could theoretically recommend a daily regimen of ginkgo to people at high risk of stroke as a preventive measure against brain damage.”

Related Links:
Johns Hopkins University


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: Private equity firms Blackstone and TPG have joined forces to acquire Hologic in a major healthcare deal (Photo courtesy of Hologic)

Hologic to be Acquired by Blackstone and TPG

Hologic (Marlborough, MA, USA) has entered into a definitive agreement to be acquired by funds managed by Blackstone (New York, NY, USA) and TPG (San Francisco, CA, USA) in a transaction valued at up to... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.